New medicine for anemia in dialysis patients
Treatments studied
Part of Blood & lymphatic clinical trials.
This study tests an experimental medicine for anemia in people with kidney disease who are on dialysis. It aims to see if it can help raise blood counts safely compared to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need to be on hemodialysis (a treatment that cleans your blood) three times a week for at least 3 months.
- Your blood hemoglobin (a protein that carries oxygen) should be in a certain range, and your iron levels must be adequate.
- You must have been taking a stable dose of an anemia medication (ESA) for the last 10 weeks.
- You cannot have a history of certain blood diseases, cancer, active bleeding, or recent heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two anemia medicines for people with chronic kidney disease (CKD) who are not on dialysis. It aims to find a more convenient pill option (daprodustat) versus a commonly used injection (epoetin alfa).
This study tests a new drug called Efepoetin Alfa to treat anemia in people with chronic kidney disease who are on dialysis. The goal is to see if it can safely raise red blood cell levels and reduce the need for other anemia treatments.
This study is collecting information from people with chronic kidney disease and anemia who are taking a medication called daprodustat. The goal is to learn more about how well it works and how it affects patients in real life.
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
This study tests a new pill, vadadustat, for people on dialysis who have anemia. It looks at whether switching from the current treatment (Epogen) to this pill is safe and works well.
This trial tests enarodustat, a pill for anemia, in people with chronic kidney disease who are not on dialysis. It aims to see if it can safely raise hemoglobin levels.
Hear when a new Anaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.